September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Drew Moghanaki: The Results from the Phase 3 HARMONi Trial Will be Presented at WCLC25
Aug 14, 2025, 16:44

Drew Moghanaki: The Results from the Phase 3 HARMONi Trial Will be Presented at WCLC25

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:

“UCLA’s Jonathan Goldman is scheduled to take the stage at WCLC25 to present the results from the phase 3 HARMONi study demonstrating the benefit of Ivonescimab in 2L for pts progressing through osimertinib with little to no more side effects!”

IASLC The 2025 World Conference on Lung Cancer Lung Cancer Europe

More posts featuring Drew Moghanaki on OncoDaily.